Position in EBS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$561,007
-$5,202 QoQ
Shares Held
66,946
-1.9% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 194 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. EBS ranks #33 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,437,213 | $103,278,126 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
120,078 | $65,061,862 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
312,832 | $52,724,705 | |
| 4 | VTRS |
Viatris Inc
|
2,872,464 | $45,614,728 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,264,159 | $31,110,952 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
633,778 | $21,973,083 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
197,060 | $21,861,836 | |
| 8 | ALKS |
Alkermes plc.
|
387,999 | $20,331,147 |
All Filings in EBS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $561,007 | 66,946 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $566,209 | 68,218 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $848,699 | 68,665 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $713,167 | 80,858 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $536,079 | 84,025 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $42,432 | 8,731 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $97,884 | 10,239 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $102,287 | 12,250 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $120,195 | 17,624 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $221,486 | 87,544 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $204,724 | 85,302 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $282,662 | 83,136 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,181,600 | 160,762 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,640,568 | 158,356 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,785,258 | 151,165 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,163,738 | 150,726 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,519,424 | 145,600 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,857,865 | 142,666 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $6,135,833 | 141,151 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $7,460,580 | 149,003 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $9,112,763 | 144,670 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $11,525,764 | 124,053 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $11,664,934 | 130,189 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $13,112,473 | 126,899 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $11,064,240 | 139,912 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $8,477,300 | 146,514 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||